2m 2m 2m 2m 2m 2m 2m
Nymox Pharma (NYMXF)
OTC
$0.02+$0.010 (+98.02%)
Price as of Jul 30, 2026- $18.1MMarket Cap
- -75.37%1-Year Change
- BiotechnologyIndustry
Nymox Pharma (NYMXF)
$0.02+$0.010 (+98.02%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 19
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.02
$0.02
$0.02
1-Year Range
$0.006
$0.15
$0.02
Latest Close$0.02
Change
+$0.010 (+49.50%)
Volume30,000
Market Cap$18.1M
Shares Outstanding90.5M
P/E (TTM)-2.75
Diluted EPS (TTM)-$0.07
Enterprise Value$16.7M
Information as of 07/30/2026
Company Profile
NYMOX PHARM CORP
$18.1M
Market Cap
-$6.6M
Net Income
Sector: Healthcare
Industry: Biotechnology
NYMOX PHARM CORP
Key Executives
- Patrick Doody
- Paul Averback DABP
- Lin Dodd
Current Ownership Distribution
- Other94.5M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)